Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

Hamann, Philip R

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. [electronic resource] - Bioconjugate chemistry - 47-58 p. digital

Publication Type: Journal Article

1043-1802

10.1021/bc010021y doi


Acute Disease
Aminoglycosides
Animals
Anti-Bacterial Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antigens, CD--immunology
Antigens, Differentiation, Myelomonocytic--immunology
Cross-Linking Reagents
Gemtuzumab
HL-60 Cells
Humans
Immunotoxins--therapeutic use
Indicators and Reagents
Leukemia, Myeloid--drug therapy
Mice
Mice, Nude
Neoplasm Transplantation
Sialic Acid Binding Ig-like Lectin 3
Tumor Cells, Cultured